INTRICARE is an interdisciplinary and international consortium involving 4 leading academic institutions and 9 SME's from 5 countries. The 15 Early Stage Researchers (ESRs) will engage in network-wide training events, public engagement activities and international collaboration through secondments, at industrial or academic partner institutions within the EU.
The INTRICARE consortium aspires to train 15 ESRs that have the skills and knowledge to contribute to the understanding of microcalcifications in vulnerable plaque formation and translation of novel insights into meaningful clinical interventions for this multi-faceted disease. The INTRICARE training programme will deliver to our group of ESRs multidisciplinary scientific and technical skills, while exploiting the specific research expertise and infrastructure of INTRICARE beneficiaries and of the collective expertise of the INTRICARE network as a whole. Importantly, the network is formed by leading institutes and companies in the fields of calcification, atherosclerosis, imaging and nutraceutical and pharmaceutical cardiovascular strategies.
INTRICARE is shaped to address the urgent, unmet medical needs concerning vulnerable plaques and is guided by the academic and industrial demand for a new generation of entrepreneurial scientists that have the skills, expertise and know-how to expedite our understanding of early atherogenesis and translation thereof into concrete clinical interventions for prevention and therapy. Organised around three pillars, notably initiation of atherogenesis, vascular remodelling associated microcalcification and imaging of microcalcification and vulnerable plaque formation, three front-running research institutes in the field of vascular biology will address the mentioned needs through training and research. Each of the three themes will incorporate both basic and translational science and education, supported by a strong network of academic and non-academic partner organisations.
The INTRICARE ESRs will be pivotal in the identification of selective targets for vascular calcification including microcalcification, and its consequences for plaque stability, and provide subsequent strategies for prevention or amelioration of vulnerable plaque formation, both during as well as beyond the INTRICARE project. Moreover, the INTRICARE consortium is shaped to cover the complete spectrum of relevant expertises from vascular biology to clinical disciplines such as Radiology, Cardiology, Nephrology, Pharmacology and includes a number of private partners, which not only ensures smooth translation of new findings into the clinical practice but also creates a scientific setting that encourages PhD trainees to think and act multidisciplinary and translational.
The MSCA-ITN funding scheme offers attractive salary and working conditions, including family allowance depending on the candidates' status at the time of recruitment.